Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, June 3, 2016
Federal Grand Jury Expands Criminal Charges Against Penn ... Paulick Report-Jun 2, 2016
Federal Grand Jury Expands Criminal Charges Against Penn ...
Paulick Report-Jun 2, 2016
The case was investigated by the Federal Bureau of Investigation, the Pennsylvania Department of Agriculture's Horse Racing Commission and the Federal ...
Penn National horse trainer facing additional criminal charges
PennLive.com-Jun 2, 2016
The additional charges brought against her are part of a wide-reachinginvestigation at Penn National Race Course that has uncovered trainers dopinghorses ...
WADA heard of Russian doping in 2010, didn't investigate until media reports
Slow response leaves anti-doping agency's effectiveness, priorities in question.
Washington Post - 15 hours ago
Thursday, June 2, 2016
Recent New York Medicaid Settlement with Pharmacy Shows ...
The National Law Review-5 hours ago
A New York pharmacy has agreed to pay approximately $500,000 to the State of New York for improperly billing New York Medicaid for prescriptions written by a
CWCI Finds Consistent Outcomes in California Workers' Comp ...
Business Wire (press release)-1 hour ago
Once again, opioid painkillers and compounded drugs together accounted for about 40% of the first quarter prescription drug IMRs, even though the IMR uphold ..
Animal Drug Approvals June 2016 Update (Green Book) – http://www.fda.gov/downloads/
Visit our home page at http://www.fda.gov/
FDA whacks Megafine India plant with warning for faked test data
Tuesday, May 31, 2016
Faking data has won another Indian drugmaker a stern warning from the FDA. This time it is for a Megafine Pharma plant whose products the FDA banned last year for the kind of data integrity shenanigans that inspectors have found repeatedly in Indian drug and API plants, indicating that some companies refuse to change until they get caught.
Subscribe to:
Posts (Atom)